The Access to Insight Basic Research Grant with a value of up to € 70,000 is for basic science or translational research relevant to the understanding of the pathophysiology and treatment of haemostatic disorders. The grant can be used to cover salary and/or project costs over a 12–18 month period.
The research priorities are the interactions of blood coagulation components (cells and proteins) and treatment of haemophilia and other rare bleeding disorders, such as von Willebrand disease, Glanzmann’s thrombasthenia and congenital factor VII deficiency. Topics could include the following:
In order to maintain a focus on interactions of blood coagulation components and treatment of haemophilia and other rare bleeding disorders, Access to Insight basic research grants will not support research focused on:
It is assumed that a maximum of 20% of the total grant can be assigned to the candidate’s institute as overhead costs.
The quality of the project idea is the main criterion for the proposal evaluation. Applications from previous grant recipients will not be considered until a period of at least two years has passed from receiving previous grant funding.
The conditions of the Access to Insight programme require that any additional funding for the same project from other sources (e.g. WFH, ISTH-SSC) be declared to both funding sources. We appreciate grant recipients’ cooperation in this regard.
Download or upload your application form here.
Please click here for more information about the application review process.
December 1st, 2025
Open for Applications
April 1st, 2025
Application Deadline
April-May 2025
Review and Selection
July 2025
Notification of recipient
September 2025
Funding Available
Services
Newsletter
The Haemophilia Academy is an independently run training programme led by a distinguished faculty of haemophilia experts.
More